Unusual LINC01018: A Potential Drug Target Or Biomarker (G255167)

Target Name: LINC01018

NCBI ID: G255167

LINC01018

Other Name(s): Long intergenic non-protein coding RNA 1018, transcript variant 1 | SRHC | Long intergenic non-protein coding RNA 1018, transcript variant 2 | long intergenic non-protein coding RNA 1018

Unusual LINC01018: A Potential Drug Target Or Biomarker

LINC01018 is a non-protein coding RNA (ncRNA) molecule that has been identified by bioinformatics analysis as belonging to the LINC (Long non-coding RNAs) family. This family ofncRNA molecules has been shown to play important roles in various cellular processes, including gene regulation, DNA replication, and RNA metabolism.

One of the key features of LINC01018 is its unique 3'-end, which is unusual for an ncRNA molecule. This 3'-end consists of a splicing intron and a splice site, which are responsible for the exonization of the RNA molecule into its final product. The splice site is a critical region of the RNA molecule that determines the final structure of the molecule and is involved in the formation of stable RNA structures.

In addition to its unusual 3'-end, LINC01018 also has a unique transcript variant. This variant is a single-base change, which involves the substitution of a thymine (T) for a guanine (G) at position +614 in the RNA molecule. This single-base change is significant because it changes the reading frame of the RNA molecule, which affects the way the molecule is translated into protein.

The function of LINC01018 is not well understood, but it is possible that it plays a role in the regulation of gene expression. This is suggested by the fact that LINC01018 is located in the genic region of many gene promoters and that it has been shown to interact with the protein encoded by the gene it is located in. Additionally, LINC01018 has been shown to be expressed in a variety of tissues and cells, including human brain, heart, and liver, which suggests that it may be involved in the regulation of cellular processes specific to these tissues.

Another potential function of LINC01018 is as a biomarker for disease. This is suggested by the fact that LINC01018 has been shown to be altered in a variety of diseases, including cancer, neurodegenerative diseases, and mental disorders. Additionally, LINC01018 has been shown to be involved in the regulation of cellular processes that are implicated in these diseases, such as cell division, apoptosis, and inflammation.

In conclusion, LINC01018 is an unusual and unique non-protein coding RNA molecule that has been identified by bioinformatics analysis as belonging to the LINC family. Its 3'-end and unique transcript variant make it different from other ncRNA molecules, and its function as a biomarker for disease and its involvement in the regulation of gene expression suggest that it may be a promising drug target or biomarker. Further research is needed to fully understand the role of LINC01018 in cellular processes and its potential as a therapeutic agent.

Protein Name: Long Intergenic Non-protein Coding RNA 1018

The "LINC01018 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01018 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets